Lv0
0 积分 2024-05-14 加入
Secukinumab in the Treatment of Hidradenitis Suppurativa
10小时前
已完结
Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Secukinumab: Dose Exploration in Pediatric Patients with Plaque Psoriasis
12小时前
已完结
Calculating the Charcoal Blockade Efficiency for Bioequivalence Study of Inhaled Ipratropium Bromide Using A Model Method
2个月前
已完结
Population Pharmacokinetic and Exposure-Response Analysis to Support a Dosing Regimen of CPX-351 (NS-87) in Japanese Adult and Pediatric Patients with Untreated High-Risk Acute Myeloid Leukemia
5个月前
已关闭
Bioequivalence of Meloxicam Nanocrystal Injection in Healthy Chinese Volunteers
1年前
已完结
Anaemia in CKD 1-5
1年前
已完结
A Model-Informed Approach to Accelerate the Clinical Development of Janagliflozin, an Innovative SGLT2 Inhibitor
1年前
已完结
Dosage exploration of meloxicam according to CYP2C9 genetic polymorphisms based on a population pharmacokinetic‐pharmacodynamic model
1年前
已完结
皖公网安备34019202002308
